Phospholipase A2 (PLA2) which catalyzes the hydrolysis of membrane phospholipids has been implicated in various inflammatory diseases, including rheumatoid arthritis and septic shock. Long-term objectives of this research program are to elucidate the mechanisms by which pro-inflammatory PLA2 is regulated and to develop therapeutic methods for treating PLA2-mediated inflammatory diseases. To date the mainstay of PLA2 inhibition has been the active-site-directed inhibitors most of which lack either efficacy or specificity under physiological conditions. To develop an alternative approach to specific PLA2 inhibition, they have extensively studied the interactions of PLA2 with membranes (interfacial binding) and found that major classes of mammalian PLA2s have distinct interfacial binding modes. They propose to take advantage of these distinct membrane-binding properties in developing chemical and biological agents that specifically block the interfacial binding of two putative pro-inflammatory PLA2, secretory Class II PLA2 (hs-PLA2) and cytosolic PLA2 (cPLA2).
The Specific Aims during this proposed period are; (1) to determine the exact differences in interfacial binding mode between two secretory PLA2s; (2) to study the mechanism by which heparin regulates the in vitro and in vivo activity of hs-PLA2, identify the heparin-binding residues of hs-PLA2 and finally develop heparin derivatives with high hs-PLA2-inhibitory activity and low anti-coagulant activity; (3) to determine how differently cPLA2 interacts with membranes and how its interfacial binding is regulated by calcium and phosphorylation and identify interfacial binding residues of cPLA2. The principal methodologies they shall use include; (1) many recombinant DNA techniques for the site-directed mutagenesis and the over-expression of PLA2s; and (2) kinetic and membrane-binding analyses of PLA2 using the polymerized mixed liposome system developed in this laboratory which allows the systematic and independent analysis of the interfacial binding and catalytic steps.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM052598-02
Application #
2459616
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1996-08-01
Project End
2000-07-31
Budget Start
1997-08-01
Budget End
1998-07-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Illinois at Chicago
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
121911077
City
Chicago
State
IL
Country
United States
Zip Code
60612
Kim, Hyunjin; Afsari, Hamid Samareh; Cho, Wonhwa (2013) High-throughput fluorescence assay for membrane-protein interaction. J Lipid Res 54:3531-8
Sheng, Ren; Chen, Yong; Yung Gee, Heon et al. (2012) Cholesterol modulates cell signaling and protein networking by specifically interacting with PDZ domain-containing scaffold proteins. Nat Commun 3:1249
McCary, Christine A; Yoon, Youngdae; Panagabko, Candace et al. (2012) Vitamin E isoforms directly bind PKC? and differentially regulate activation of PKC?. Biochem J 441:189-98
Bolger, Joshua K; Tian, Wen; Wolter, William R et al. (2011) Synthesis and evaluation of 5-lipoxygenase translocation inhibitors from acylnitroso hetero-Diels-Alder cycloadducts. Org Biomol Chem 9:2999-3010
Morales, Krystal A; Lasagna, Mauricio; Gribenko, Alexey V et al. (2011) Pb2+ as modulator of protein-membrane interactions. J Am Chem Soc 133:10599-611
Chen, Wei; Goldfine, Howard; Ananthanarayanan, Bharath et al. (2009) Listeria monocytogenes phosphatidylinositol-specific phospholipase C: Kinetic activation and homing in on different interfaces. Biochemistry 48:3578-92
Manna, Debasis; Bhardwaj, Nitin; Vora, Mohsin S et al. (2008) Differential roles of phosphatidylserine, PtdIns(4,5)P2, and PtdIns(3,4,5)P3 in plasma membrane targeting of C2 domains. Molecular dynamics simulation, membrane binding, and cell translocation studies of the PKCalpha C2 domain. J Biol Chem 283:26047-58
Tian, Wen; Wijewickrama, Gihani T; Kim, Jung Hwan et al. (2008) Mechanism of regulation of group IVA phospholipase A2 activity by Ser727 phosphorylation. J Biol Chem 283:3960-71
Bhardwaj, Nitin; Stahelin, Robert V; Zhao, Guijun et al. (2007) MeTaDoR: a comprehensive resource for membrane targeting domains and their host proteins. Bioinformatics 23:3110-2
Stahelin, Robert V; Subramanian, Preeti; Vora, Mohsin et al. (2007) Ceramide-1-phosphate binds group IVA cytosolic phospholipase a2 via a novel site in the C2 domain. J Biol Chem 282:20467-74

Showing the most recent 10 out of 70 publications